Back to Thymosin Alpha-1
Thymosin Alpha-1 Dosage Guide
Complete dosing protocol, reconstitution steps, and interactive calculator for Thymosin Alpha-1.
Dosing & Reconstitution Guide
Clinical use abroad typically involves 1.6 mg injected subcutaneously 1–2 times weekly. These regimens are not approved in the U.S.
Standard / Gradual Approach
5mg VialstandardPhaseDoseVolume
Week 1300 mcg (0.3 mg)18 units (0.18 mL)
Weeks 2–8500 mcg (0.5 mg)30 units (0.30 mL)
Standard / Gradual Approach
10mg VialstandardPhaseDoseVolume
Week 1300 mcg (0.3 mg)9 units (0.09 mL)
Weeks 2–8500 mcg (0.5 mg)15 units (0.15 mL)
Protocol Summary
Subcutaneous (SQ): 2-3 times per week · Dose range 0.8–3.2 mg with gradual titration
Cycle Length: 4–8 weeks typical; reassess before extending
Frequency & Cycling
SubQ Injection
Administer 1.6 mg SubQ injection 2–3 times weekly. Standard cycle: 6–12 weeks. Maintenance protocols vary by condition; periodic reassessment of immune markers recommended.
🧪 Quick Start
Vial Size
10 mg
BAC Water
3 mL
Concentration
3300 mcg/unit
Starting Dose
300 mcg (0.3 mg) (9 units (0.09 mL))
Maintenance Dose
500 mcg (0.5 mg) (15 units (0.15 mL))
🧮 Dose Calculator
Concentration
33.3
mcg/unit
Draw Volume
15
units (0.150 mL)
For a 500 mcg dose, draw 15 units on a U-100 insulin syringe